Table 2.
Review of donor site complications across 10 studies.
| Study | Year | Study Type | Hematoma | Wound Dehiscence | Wound Infection | Seroma | Total Flap Loss |
|---|---|---|---|---|---|---|---|
| Hunter et al | 2015 | PC | - | 4.50% | - | 4.50% | 9.09% |
| Haddad et al | 2016 | PC | - | - | - | 6.67% | 6.67% |
| Ito et al | 2016 | RR | - | - | - | - | - |
| Hupkens et al | 2016 | PC | - | 10% | - | - | - |
| Allen et al | 2016 | RR | 1.90% | 3.60% | - | 6% | 0.61% |
| Haddock et al | 2017 | RR | - | 10.89% | 5.90% | - | 1.98% |
| Fosseprez et al | 2017 | RR | 5.8%* | - | - | 35.30% | 11.80% |
| Haddock et al | 2019 | RR | - | 3% | - | - | - |
| Haddock et al | 2020 | RR | 2.60% | 6.80% | 4.90% | 4.50% | 3% |
| Atzeni et al | 2021 | PC | 1.70% | 2.60% | - | 2.60% | - |
RR: Retrospective Review; PC: Prospective Cohort Study; * denotes recipient site complication